31 research outputs found

    Motile aeromonads from farmed and wild freshwater fish in northern Italy: an evaluation of antimicrobial activity and multidrug resistance during 2013 and 2016

    Get PDF
    Background Antimicrobial resistant bacteria are emerging biological contaminants of the environment. In aquatic ecosystems, they originate mainly from hospitals, livestock manure and private households sewage water, which could contain antimicrobial agents and resistant microorganisms. Aeromonas spp. occur ubiquitously in aquatic environments and they cause disease in fish. Motile aeromonads are also associated with human gastrointestinal and wound infections and fish can act as a transmission route of antimicrobial resistance (AMR) aeromonads to humans. The environmental ubiquity, the natural susceptibility to antimicrobials and the zoonotic potential of Aeromonas spp. make them optimal candidates for studying the AMR in aquatic ecosystems. Results The AMR patterns of 95 motile aeromonads isolated from freshwater fish during 2013 and 2016 were analyzed. All samples from fish came from farms and natural water bodies located in northern Italy, which is an area characterized by high anthropic impact on the environment. The isolates were biochemically identified as Aeromonas hydrophila, Aeromonas sobria or Aeromonas caviae and AMR was determined by the standard disk diffusion method. All isolates were resistant to cloxacillin, spiramycin and tilmicosin. High AMR frequencies (>\u200995%) were detected for tylosin, penicillin and sulfadiazine. AMR to danofloxacin, enrofloxacin, flumequine, ceftiofur, aminosidine, colistin, doxycycline, gentamicin, marbocyl and florfenicol was observed at low levels (<\u200910%). No AMR to cefquinome was found. Logistic regression showed several differences in antimicrobial activity between complexes. According to the source of aeromonads, only few differences in AMR between isolates from farmed and wild fish were observed. Conclusions Our data revealed an increasing trend of AMR to neomycin and apramycin among Aeromonas isolates during the study period, while resistance to erythromycin, tetracycline and thiamphenicol decreased. All isolates were multidrug resistance (MDR), but A. caviae showed the highest number of MDR per isolate. In most isolates, various degrees of MDR were detected to macrolides, quinolones, fluoroquinolones, polymyxins and cephalosporins (third and fourth generations), which are listed, by the World Health Organisation, to be among the highest priority and critically important antimicrobials in human medicine. Our findings underlined that freshwater fish can act as potential source of MDR motile aeromonads. Due to their zoonotic potential, this can pose serious threat to human health

    Nonredundant role of CCRL2 in lung dendritic cell trafficking.

    Get PDF
    Chemokine CC motif receptor-like 2 (CCRL2) is a heptahelic transmembrane receptor that shows the highest degree of homology with CCR1, an inflammatory chemokine receptor. CCRL2 mRNA was rapidly (30 minutes) and transiently (2-4 hours) regulated during dendritic cell (DC) maturation. Protein expression paralleled RNA regulation. In vivo, CCRL2 was expressed by activated DC and macrophages, but not by eosinophils and T cells. CCRL2(-/-) mice showed normal recruitment of circulating DC into the lung, but a defective trafficking of antigen-loaded lung DC to mediastinal lymph nodes. This defect was associated to a reduction in lymph node cellularity and reduced priming of T helper cell 2 response. CCRL2(-/-) mice were protected in a model of ovalbumin-induced airway inflammation, with reduced leukocyte recruitment in the BAL (eosinophils and mononuclear cells) and reduced production of the T helper cell 2 cytokines, interleukin-4 and -5, and chemokines CCL11 and CCL17. The central role of CCRL2 deficiency in DC was supported by the fact that adoptive transfer of CCRL2(-/-) antigen-loaded DC in wild-type animals recapitulated the phenotype observed in knockout mice. These data show a nonredundant role of CCRL2 in lung DC trafficking and propose a role for this receptor in the control of excessive airway inflammatory responses. (Blood. 2010;116(16):2942-2949

    Esbl/ampc-producing escherichia coli in wild boar: Epidemiology and risk factors

    Get PDF
    The complex health problem of antimicrobial resistance (AMR) involves many host species, numerous bacteria and several routes of transmission. Extended-spectrum β-lactamase and AmpC (ESBL/AmpC)-producing Escherichia coli are among the most important strains. Moreover, wildlife hosts are of interest as they are likely antibiotics free and are assumed as environmental indicators of AMR contamination. Particularly, wild boar (Sus scrofa) deserves attention because of its increased population densities, with consequent health risks at the wildlife–domestic–human interface, and the limited data available on AMR. Here, 1504 wild boar fecal samples were microbiologically and molecularly analyzed to investigate ESBL/AmpC-producing E. coli and, through generalized linear models, the effects of host-related factors and of human population density on their spread. A prevalence of 15.96% of ESBL/AmpC-producing E. coli, supported by blaCTX-M (12.3%), blaTEM (6.98%), blaCMY (0.86%) and blaSHV (0.47%) gene detection, emerged. Young animals were more colonized by ESBL/AmpC strains than older subjects, as observed in domestic animals. Increased human population density leads to increased blaTEM prevalence in wild boar, suggesting that spatial overlap may favor this transmission. Our results show a high level of AMR contamination in the study area that should be further investigated. However, a role of wild boar as a maintenance host of AMR strains emerged

    Activin A Induces Langerhans Cell Differentiation In Vitro and in Human Skin Explants

    Get PDF
    Langerhans cells (LC) represent a well characterized subset of dendritic cells located in the epidermis of skin and mucosae. In vivo, they originate from resident and blood-borne precursors in the presence of keratinocyte-derived TGFβ. Ιn vitro, LC can be generated from monocytes in the presence of GM-CSF, IL-4 and TGFβ. However, the signals that induce LC during an inflammatory reaction are not fully investigated. Here we report that Activin A, a TGFβ family member induced by pro-inflammatory cytokines and involved in skin morphogenesis and wound healing, induces the differentiation of human monocytes into LC in the absence of TGFβ. Activin A-induced LC are Langerin+, Birbeck granules+, E-cadherin+, CLA+ and CCR6+ and possess typical APC functions. In human skin explants, intradermal injection of Activin A increased the number of CD1a+ and Langerin+ cells in both the epidermis and dermis by promoting the differentiation of resident precursor cells. High levels of Activin A were present in the upper epidermal layers and in the dermis of Lichen Planus biopsies in association with a marked infiltration of CD1a+ and Langerin+ cells. This study reports that Activin A induces the differentiation of circulating CD14+ cells into LC. Since Activin A is abundantly produced during inflammatory conditions which are also characterized by increased numbers of LC, we propose that this cytokine represents a new pathway, alternative to TGFβ, responsible for LC differentiation during inflammatory/autoimmune conditions

    Mycoplasma bovis infection in respiratory disease of dairy calves less than one month old

    No full text
    Mycoplasma bovis is an important cause of bovine respiratory disease, especially in young calves where it can also cause arthritis, tenosynovitis and otitis. During 2009 and 2010 a survey was carried out on carcasses of calves less than one month old sent to the Diagnostic Laboratory of the Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna in Brescia, regardless of the presence of lung lesions, to detect this pathogen. PCR tests for Mycoplasma spp. and M. bovis were applied. 83 out of 224 (37%) lung tissue samples examined were positive at PCR test for Mycoplasma spp.; in 64 cases of these we observed typical respiratory lesions (P< 0.001). M. bovis was identified in 26 out of 83 (31%) lung tissue samples positive at PCR test for Mycoplasma spp.; in 24 cases of these we observed typical respiratory lesions (P= 0.039). Our data demonstrate that presence of Mycoplasma spp. and M. bovis positively correlates with pneumonic lung lesions in young dairy calve

    Indagine sulla patogenicit&#224; di ceppi mobili di aeromonas spp. isolati da specie ittiche

    No full text
    Lo studio della patogenicit\ue0 di Aeromonas spp. \ue8 caratterizzato da notevole complessit\ue0, sviluppandosi in genere su pi\uf9 livelli e comprendendo saggi biologici in vitro (linee cellulari) ed in vivo (modelli animali), esami molecolari ed analisi delle propriet\ue0 fenotipiche degli isolati. Nell\u2019ambito di una tesi di specialit\ue0 (Allevamento, Igiene, Patologia delle Specie Acquatiche e Controllo dei Prodotti Derivati) sulla caratterizzazione in vitro della virulenza di questi microrganismi, sono stati esaminati 101 ceppi di Aeromonas mobili, provenienti da specie ittiche selvatiche (69), allevate (26), ed ornamentali (6). L\u2019isolamento \ue8 avvenuto da pesci setticemici (27) e apparentemente sani (74). Per ciascuno degli isolati, identificati biochimicamente a livello di complex, sono state analizzate le propriet\ue0 citotossiche su tre diverse linee cellulari (EPC, BF2, Vero) ed una serie di caratteristiche colturali (crescita a 37\ub0C, emolisi), biochimiche (test VP, decarbossilazione della lisina, fenomeno del suicidio) ed enzimatiche (lipasi, gelatinasi) indicate in letteratura come potenziali fattori di virulenza di Aeromonas spp. In particolare, si \ue8 indagato sulla correlazione fra questi fattori, la fenospecie dei ceppi (A. hydrophila, A. sobria, A. caviae), la provenienza (selvatica, allevata) ed il quadro clinico delle specie ittiche d\u2019isolamento. In generale, lo studio ha registrato alte prevalenze (54.5-99.0%) dei potenziali indicatori di patogenicit\ue0 all\u2019interno del campione testato. La produzione di lipasi (98.0%) e gelatinasi (99.0%) \ue8 stata il fattore pi\uf9 frequentemente riscontrato. Anche le caratteristiche colturali/biochimiche hanno mostrato un\u2019ampia diffusione fra i ceppi esaminati, con prevalenze variabili dal 70.3% (crescita a 37\ub0C) al 94.1% (fenomeno del suicidio: attivit\ue0 non suicida). L\u2019attivit\ue0 citotossica ha rappresentato il fattore di virulenza meno prevalente (54.5%). Dai risultati \ue8 emersa una correlazione della capacit\ue0 di crescita a 37\ub0C, attivit\ue0 emolitica e citotossica con la fenospecie dei ceppi, in particolare con i complex A. caviae (crescita a 37\ub0C) ed A. hydrophila (attivit\ue0 emolitica e citotossica). Ad esclusione dell\u2019azione decarbossilasica sulla lisina, prevalente negli isolati selvatici, nessuno dei markers di virulenza \ue8 risultato associato all\u2019origine dei ceppi. Solamente la crescita a 37\ub0C \ue8 stata correlata con presenza di patologia nei pesci, indicando una scarsa significativit\ue0 dei fattori fenotipici analizzati nella caratterizzazione in vitro in tal senso della patogenicit\ue0 di Aeromonas spp. Dei sistemi cellulari testati, le cellule Vero si sono dimostrate le pi\uf9 sensibili alle citotossine prodotte da Aeromonas spp. Si ritiene comunque che l\u2019importanza di utilizzare le cellule Vero sia legata, oltre ad una migliore visualizzazione dell\u2019effetto citopatico, anche alla possibilit\ue0 di individuare ceppi in grado di esprimere il loro potenziale patogeno nei mammiferi e nell\u2019uomo, il quale andrebbe per\uf2 confermato mediante l\u2019impiego dei tradizionali modelli animali. Ulteriori studi si rendono necessari per meglio definire il significato clinico dei fattori di virulenza di Aeromonas spp. nei pesci, da eseguirsi su un maggior numero di isolati ed associando l\u2019esame dei caratteri fenotipici dei ceppi alle analisi molecolari e, soprattutto, alle prove biologiche in vivo

    MANUALE PER LA GESTIONE DEL CONTROLLO DEL BENESSERE DEI PESCI DURANTE IL TRASPORTO SU STRADA

    No full text
    REGOLAMENTO n. 1/2005 CE del Consiglio, del 22 Dicembre 2004 sulla protezione degli animali durante il trasporto e le operazioni correlat
    corecore